StockData

Generate Biomedicines, Inc. (GENB) stock

GENBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$9.84−0.65 (-6.20%)

Close on Nov 17, 2026Market cap $1.26BP/E –Yield –

Generate Biomedicines market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Generate Biomedicines's market cap was $1.73B on Nov 11, 2026.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.73B–

More Generate Biomedicines figures

See a number that looks wrong?